PBS Website Update - 1 April 2026
Page last updated: 1 April 2026
The Schedule of Pharmaceutical Benefits has been updated. New, Amended and Deleted items can be found on the Summary of Changes page.
The following updates have also been made to the PBS Website on the dates specified.
- PBS listing update for macrogol 3350, sachets containing powder for oral solution 13.125 g with electrolytes, 30, oral, effective - 1 April 2026
- Designated Brands - 1 April 2026
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 April 2026
- PBS restriction changes for antihypertensive dual therapy fixed dose combinations - 1 April 2026
- Ex-manufacturer price - 1 April 2026
- Formulary Allocations - 1 April 2026
- First New Brand Price Reductions - 1 April 2026
- Items Exempt from Statutory Price Reductions - 1 April 2026
- Drugs subject to Price Disclosure - 1 April 2026
- Medicine Status Website - 1 April 2026
- Agenda for the July 2026 PBAC meeting – 25 March 2026
- PBAC Public Summary Documents (first time decisions not to recommend and deferrals) – November 2025 meeting - 20 March 2026
- Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 20 March 2026
- PBS and RPBS Section 85 and Section 100 Date of Supply Data - 17 March 2026
- PBAC advice on equitable access to GLP-1 obesity treatments - 17 March 2026
- Recommendations made by the PBAC – December 2025 Intracycle Meeting - 13 March 2026
- Public consultation open for revised Code of Ethics for Pharmacists - 11 March 2026
- PBAC Public Summary Documents – November 2025 meeting - 6 March 2026
